We are Staying Within the Biotech Sector this Week

We are Staying Within the Biotech Sector this Week

We are staying within our biotech watch-list with a second biotech feature this week coming your way tomorrow 12-09-20 at market open. Be ready…

Good day everyone,

As 2020 comes to an end, we reflect on the success of this newsletter. The past decade (yes, we’ve been around that long) was great as we heard from our members about their success, they experienced utilizing our reports.

With well over 2,000% in potential gains logged for 2020 we can’t help but be excited for the potential of the 2020’s decade.

We just looked at a public list of the day’s top gaining stocks. Six of those ten were in the biotech sector. Today was not an anomaly, biotech has dominated the top gainers list quite a bit and most of these dynamic stocks are listed on the NASDAQ.

That is why we focus on the biotech sector and the NASDAQ, not exclusively, but a good portion of our reporting falls within those parameters.

Some of the companies we report to you have been under our watch for years before we talk about them. We report to you as the technical, fundamental overall picture presents a potential near-term gain with long term prospects. With biotech and pharma we enjoy reporting positive progress with their clinical trials as they achieve milestones along the way.

As we discussed earlier, the biotech/biopharma sector is coming into its own. There are hundreds of NASDAQ companies working on cures and treatments for some of the most insidious human conditions. Diabetes, cancer, and pulmonary indications are huge potential markets and the number of companies developing treatments for them are many.

Those companies working on “orphan drugs” for rare diseases or indications get our attention as well because no one knows what broader use those treatments may eventually lead to. Conversely, biopharma companies that are developing effective treatments for acute respiratory distress syndrome (ARDS) due to covid-19. Once covid-19 is gone, those same treatments may help those cases of ARDS that are independent of covid-19.

We will continue to report on biotech stocks, of course, but we also keep close tabs on other exciting sectors such as alternative energy, electric vehicles, junior miners, cannabis/hemp, and new/disruptive tech. These are sectors we look toward for high growth in the coming decade.

And we always have an eye out for oversold companies where their stock is trading below book, at a fraction of the company sales, with low P/E values, and other technical or financial metrics that indicate potential oversold shares.

Be prepared for tomorrow at market open.

Stay tuned and stay informed,

The Traders News Group


Privacy Policy and Disclaimer
Your Consent
By using our site, you consent to our online privacy policy and disclaimer.
Do we disclose any information to outside parties?
We do not sell your information to anyone. Please see our cookie policy below
What information do we collect?
We collect information from you when you subscribe to our newsletter or fill out a form on one of our social platforms. This includes your email address and or mobile phone number.
When registering on our site, as appropriate, you may be asked to enter your: e-mail address and or mobile number.
What do we use your information for?
When we collect your email or mobile number it is used for one purpose to send you the information you requested about small cap stocks. Please read our disclaimer carefully before viewing our emails.
Your information, whether public or private, will not be sold, exchanged, transferred, or given to any other company for any reason whatsoever, other than for the express purpose of delivering the information on small cap stocks that you requested.
We send periodic emails
The email address you provide may be used to send you information, respond to inquiries, and/or other requests or questions.
How do we protect your information?
We implement a variety of security measures to maintain the safety of your personal information when you enter, submit, your email address. We use secure third parties to send email and sms messages to you.
Because we value your privacy we have taken the necessary precautions to be in compliance with the California Online Privacy Protection Act. We therefore will not distribute your personal information to outside parties without your consent.
Online Privacy Policy Only
This online privacy policy applies to information collected through our website and social media platforms.
Contacting Us
If there are any questions regarding this privacy policy or disclaimer you may contact us using the information below.
Traders News Source is a wholly owned subsidiary of Traders News Source LLC, herein referred to as TNS LLC.
Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use.
PLEASE NOTE WELL: TNS LLC and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.
Release of Liability: Through use of this website viewing or using you agree to hold TNS LLC, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. TNS LLC encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and TNS LLC makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead TNS LLC strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. TNS LLC is compliant with the Can Spam Act of 2003. TNS LLC does not offer such advice or analysis, and TNS LLC further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled.
The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results.
In preparing this publication, TNS LLC has relied upon information supplied by its customers, publicly available information and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, TNS LLC and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. TNS LLC is not responsible for any claims made by the companies advertised herein, nor is TNS LLC responsible for any other promotional firm, its program or its structure.
TNS LLC is not affiliated with any exchange, electronic quotation system, the Securities Exchange Commission or FINRA. TNS LLC is not a Broker/Dealer and does not engage in high frequency trading.